Cancer Vaccine Week
Susan Hasty, Publisher
Table of Contents . . . December 29th, 2003
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Cancer Vaccine Week | Other Publications
Anticancer Therapy - The mevalonate synthesis pathway is a potential therapeutic target in cancer
Breast Cancer - Advexin vaccine therapy to begin phase I/II
Bladder Cancer - CD40 ligand immunogene therapy protects against bladder malignancies
Immunology - Transfected tumor cells boost antitumor responses in lung cancer patients
Anticancer Drug Clearance - Tumor-up-regulated cytochrome P4501B1 enzyme can be targeted by cytotoxic T cells
Antioxidants - Strawberry extract alters proliferation of HepG2 human liver cancer in vivo
Biliary Tract Cancer - Low-dose Imantinib with 5-FU holds potential for biliary tract cancers
Biliary Tract Carcer - NSAIDs may help prevent pancreaticobiliary maljunction carcinogenesis
Biological Therapy - The Th1/Tc1 circuit can produce tumor-specific CTL, even though Th2 can kill
Breast Cancer - A decreased level of ERbeta mRNA may be associated with breast tumorigenesis
Breast Cancer - Aromatase inhibitors' signal disruption mechanism differs from Tamoxifen
Breast Cancer - Combination genomics technique greatly improves breast carcinoma detection
Breast Cancer - Drug-induced apoptosis mechanism via DR-dependent pathway not fully understood
Breast Cancer - Expression of transglutaminases displayed in human breast cancer
Breast Cancer - Herstatin inhibits heregulin-mediated breast cancer cell growth
Breast and Prostate Cancer - Telomere stability correlates with longevity after exposure to radiation
Colon Cancer - CD44v6 expression may be a clinically useful indicator of colon cancer
Colon Cancer - CDX2 inactivation in colon cancer results from defects in trans-acting pathways
Colon Cancer - In vitro chemosensitivity analysis of human colon tumor cell lines shows promise
Colon Cancer - p53 gene mutations are rare in human papillomavirus-associated colon cancer
Colon Carcinoma - Detection of differentially expressed HES-6 gene in metastatic colon carcinoma
Ewing Sarcoma - Pamidronate inhibits Ewing sarcoma cell growth in vitro
Hepatocellular Carcinoma - More studies needed to reveal COX2 inhibitors affect on liver disease
Leukemia - AT islands in fragile sites can function as matrix attachment regions
Leukemia - PTEN expression in leukemic T cells leads to reduced proliferation
Lung Cancer - DNA analysis may help refine sputum exams, improve early lung cancer detection
Lung Cancer - Parathyroid hormone-related protein could promote cancer progression in vivo
Lung Cancer - Researchers establish patient-like SCID mouse model
MALT Lymphoma - Stability and subcellular localization of API2-MALT1 chimeric protein
Melanoma - Intracellular regulation of evodiamine-induced A375-S2 cell death
Multiple Myeloma - Alterations of RAS signaling are critical in multiple myeloma pathogenesis
Multiple Myeloma - High-dose chemotherapy more beneficial for MM patients with high-risk features
Multiple Myeloma - MM antigen HM1.24 loaded in adeno-associated virus produces anticancer T cells
Myeloid Tumors - Mutational analysis of ST7 do not commonly contribute to human myeloid tumors
Oncogene Activation - Poleta is important in inducing hypermutability in codon 12
Ovarian Cancer - Autoantibody to epithelial cell adhesion molecule is higher in ovarian cancer
Papillary Thyroid Carcinoma - BRAF mutations are restricted to papillary carcinomas
Pediatric Cancer - Researchers investigate alteration of the Axin gene in pediatric neoplasms
Pituitary Tumors - A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells
Prostate Cancer - GSTP1 QMSP improves sensitivity of histologic review of random needle biopsies
Prostate Cancer - NFkappaB is a pivotal transcription factor in prostate cancer metastasis to bone
Renal Cell Carcinoma - Epidermal growth factor receptor blockade may supplement cytotoxic chemotherapy
Tissue Analysis - MALDI-MS allows direct analysis of drug candidates in tissue
Tumor Inhibition - A gap junction-independent tumor-suppressing effect of connexin 43 reported
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
